Reading the SPAC Aftermarket — Deal Signals That Shape Listing Strategy

The SPAC Market Doesn't Lie

The SPAC market is one of the most information-rich environments in public finance, and most companies preparing for a listing never learn to read it. Every price quote on a SPAC unit, every PIPE term sheet, every extension vote and redemption wave is transmitting information about institutional conviction, deal appetite, and the relative attractiveness of the blank-check structure in real time. Companies that know how to interpret these signals gain a significant edge in choosing between a SPAC merger and a traditional IPO.

The market has undergone a full cycle since the 2020–2021 peak, when over 600 SPACs launched in a single year at a combined $162 billion. The washout that followed was severe. By 2023, gross SPAC proceeds had fallen to $3.4 billion. The recovery that has followed is more selective and more structurally sound. In 2024, 57 SPACs raised $9.6 billion at a median deal size of $168 million — more than double 2023's median. By 2025, approximately 133 to 144 SPAC IPOs closed, raising $25.8 billion in aggregate. In the first four months of 2026, SPACs represented approximately 61% of all U.S. IPO activity.

The structural cleanup matters. The SPACs that survived and succeeded in 2024–2026 are materially different from the 2020–2021 cohort. Repeat, experienced sponsors now dominate — 78 to 80% of new SPAC IPOs in early 2025 were by serial sponsors. Tighter timelines, cleaner structures, and more disciplined target selection have become market norms. For companies evaluating a SPAC merger, the relevant baseline is the current market, not the peak-cycle experience.

NAV Premiums and Discounts — Reading the Spread

SPAC units price at $10.00 and the trust account holds approximately that value per share throughout the search period. Where shares trade relative to that $10.00 NAV is one of the most direct available indicators of market sentiment toward the vehicle and its sponsor.

When SPAC shares trade above $10.00, the market is pricing in a belief that the eventual business combination will deliver upside above the redemption floor. Investors are choosing to pay more than they could receive back in a redemption — a signal of genuine conviction in the sponsor's deal-making ability. Trading above NAV is rare and historically predictive of low redemption rates when a deal is eventually announced.

The dominant pattern in 2024–2025 is trading at or slightly above NAV. Most investors treat the structure as a money-market instrument with an embedded call option: they will redeem unless the deal genuinely interests them. In this environment, redemption rates of 80 to 95% are common. A company evaluating a SPAC merger must understand that a $100 million trust may yield only $5 to $20 million in actual deal capital after redemptions deplete the account — and the PIPE must bridge the gap.

Rights-based SPACs carry a small but meaningful embedded premium over pure cash value. Each right converts automatically into one-quarter of an ordinary share upon deal close, without exercise payment or investor action required. Active trading in the rights above minimal value signals directional conviction on deal completion. Rights structures also avoid the “wall of warrants” problem that mechanically diluted post-close shareholders throughout the 2020–2021 era, when large warrant exercise volumes at $11.50 created persistent overhang and depressed share prices.

PIPE Terms — The Conviction Signal Institutional Investors Won't Hide

PIPE (Private Investment in Public Equity) financing has become the de facto measure of institutional conviction in a SPAC deal. When a business combination is announced and redemptions drain the trust, the PIPE bridges the funding gap between remaining trust capital and the capital required to close the transaction. The terms on which institutional investors agree to participate reveal their actual conviction level with a precision no other market signal can match.

When PIPEs price at $10.00 per share — matching the original SPAC IPO price — institutional investors are paying full price for a company whose deal has not yet closed. No redemption discount, no downside protection premium. The 2025 market saw a notable reopening of $10.00 PIPE transactions, specifically identified in Gallagher/Ellenoff's 2025 SPAC review as a leading indicator of market health restoration. A $10.00 PIPE is the clearest available signal that sophisticated institutional capital believes in both the target company and the deal structure.

PIPEs priced below $10.00 represent the investor demanding a concession for deal risk. Heavy discounts in the $8 to $9 range frequently predict post-close share price underperformance, as the discount creates an immediate overhang and signals that even the investors funding the deal have reservations about full-price value. The discount is not just a cost — it is information.

Timing and sizing matter equally. PIPEs announced concurrently with the merger agreement signal sponsor confidence and reduce financing risk compared to PIPEs negotiated in the weeks following announcement. A PIPE sized to cover projected redemptions rather than serving as a residual top-up signals that the sponsor has accurately modeled the redemption scenario. A PIPE smaller than the projected redemption wave is a structural warning sign that should prompt careful scrutiny of the deal's viability.

De-SPAC Performance — What the Data Actually Shows

The long-run performance record of de-SPAC transactions is unambiguous and must inform any company's listing structure decision. University of Florida research (Jay Ritter) covering 2012 through 2024 found that SPAC total returns were below the overall market return every single year, by as much as 73.6% in the worst year. The post-2021 cohort is particularly stark: over 90% of de-SPAC companies traded below the $10.00 IPO price within a year of closing.

In contrast, traditional IPO stocks rose nearly 29% on average in 2024, outpacing the S&P 500's 26% gain for the same period. Academic research across multiple methodologies consistently finds that SPAC mergers underperform matched IPO cohorts on both operating performance and buy-and-hold stock returns. The underperformance is not accidental — it is mechanically embedded in the structure itself.

Founder share dilution (typically 20% of post-IPO shares issued at minimal cost to the sponsor), rights or warrant conversion dilution, and PIPE discounts all create downward pressure on post-close equity value that the acquired business must overcome through exceptional operational performance. Most businesses cannot grow fast enough to absorb this structural dilution, and the public market prices that reality quickly.

The survivor bias caveat is important. The 2025 rebound SPACs — concentrated among experienced repeat sponsors with disciplined target selection — represent the top decile of the structure. A handful of 2025 transactions achieved near-zero redemption rates, demonstrating that quality execution can overcome structural headwinds. These outliers should not be used as evidence that the structure has been rehabilitated for the average issuer. The full 2025 cohort performance will not be visible until 2027–2028 holding periods mature.

Redemption Rates, Extensions, and Terminations — The Health Dashboard

Redemption rates are the most direct measure of deal quality available in real time. A low redemption rate means institutional investors chose to stay invested rather than take their $10.00 back — the strongest possible vote of confidence from the most informed market participants. A high redemption rate means the market is indifferent or skeptical about the specific deal, regardless of how the sponsor describes it.

In 2024–2025, typical redemption rates ranged from 80 to 95%+ for average SPAC deals. Rates below 40% indicate a strong deal with genuine institutional support. Near-zero redemption rates — achieved by a small number of 2025 transactions — represent exceptional deal quality and institutional alignment that is uncommon at the current stage of the SPAC cycle.

Extension dynamics are equally revealing. As of year-end 2024, 68.9% of the 196 active SPACs had taken at least one extension of their deal deadline. Extensions trigger redemption events — shareholders can redeem at each extension vote, progressively depleting the trust even before a deal is announced. A SPAC with multiple extensions and a significantly depleted trust is structurally impaired. The average time from SPAC IPO to deal close in 2024 was 35.4 months, far exceeding the original search windows these vehicles were structured around. The 15-month clocks in tighter modern structures represent a deliberate design signal: sponsor discipline and accountability to a defined timeline.

In 2024, 57 SPAC deals were terminated — roughly equal to the number of new SPAC IPOs that year — and 56 SPACs completed liquidations, returning trust capital to public shareholders. For target companies, this cleanup is constructive: the remaining active SPAC population (approximately 245 vehicles actively searching as of early 2026, holding $55.6 billion in trust) is a more credible and disciplined set of potential acquirers than the bloated 2021 peak population.

Rights vs. Warrants — The Structural Shift That Matters

The most meaningful structural evolution in the 2025–2026 SPAC market is the widespread adoption of rights-based unit structures in place of the traditional warrant model. Understanding this shift is essential for any company evaluating a SPAC merger, because the unit structure directly affects post-close dilution, cap table predictability, and institutional investor behavior.

In the traditional warrant structure, each SPAC unit included one-half or one whole warrant exercisable at $11.50 post-combination. Warrants are optional — holders exercise or not, depending on the post-close share price. For post-close shareholders, this created a persistent overhang: as the stock approached $11.50, warrant holders would exercise in large volumes, diluting existing shareholders and suppressing the share price. This "wall of warrants" was a defining structural feature of the 2020–2021 era and contributed materially to the underperformance of that cohort.

A right to receive one-quarter of an ordinary share converts automatically on deal close. There is no exercise price, no optional exercise decision, and no ongoing overhang. The dilution is fixed, predictable, and occurs once. For post-close shareholders, this creates a cleaner cap table: the exact dilution from rights conversion is known at the time of the merger vote, with no uncertainty about future exercise behavior driving price instability. Companies evaluating SPAC merger targets should favor rights-based structures over warrant-based structures for this reason alone.

Choosing Between a SPAC and a Traditional IPO

The decision between a SPAC merger and a traditional IPO is not a structural preference or a speed calculation — it is a data-driven analysis of market conditions, company readiness, and execution risk. Companies that make this decision based on speed or anecdote, rather than systematic intelligence gathering, frequently choose the wrong path and pay for it in post-close performance.

A SPAC merger can be the right choice for a company that is not yet ready for the 6 to 18 month traditional IPO timeline and SEC comment review process, provided the sponsor is experienced, the PIPE market is supportive, and redemption risk can be managed through deal quality and investor engagement. For companies in sectors experiencing strong institutional SPAC appetite, the merger path can also provide access to a broader set of investors through the PIPE process than a traditional roadshow allows.

For companies with clean financials, a compelling public market growth story, and the governance infrastructure to support SEC review, the traditional IPO consistently delivers better long-term outcomes. Institutional investors generally assign higher valuation credibility to IPO-listed companies than to de-SPAC companies — a discount that persists even with strong operational performance and is difficult to fully overcome.

Making this decision well requires current data: redemption rates for comparable SPACs, PIPE market availability and pricing in the relevant sector, traditional IPO window conditions including pricing outcomes and overallotment exercise rates, and an independent assessment of available sponsor track records. Luminark Holdings monitors all of these indicators continuously, providing clients with a data-grounded view of their optimal listing path at the moment the decision needs to be made.